LEE B. LUSTED FINALISTS' MODERATED POSTER SESSION & CONTINENTAL BREAKFAST: THIS IS A MODERATED POSTER SESSION COMPRISED OF ALL LEE B. LUSTED PRIZE FINALISTS.

Monday, October 20, 2014: 7:00 AM - 8:30 AM

* Finalists for the Lee B. Lusted Student Prize

Session Chairs:
Amber E. Barnato, MD, MPH, MS and John Wong, MD
PS2-1

* USING BIOMARKER TESTING TO TARGET TREATMENT TO PATIENTS WITH MILD COGNITIVE IMPAIRMENT AT INCREASED RISK OF ALZHEIMER'S DISEASE
Tzeyu L. Michaud, MHA and Karen M. Kuntz, ScD, University of Minnesota, Minneapolis, MN
PS2-2

* ESTIMATING PREFERENCE WEIGHTS IN OBESITY USING THE EQ-5D AND SF-6D
David D. Kim, MS and Emily Beth Devine, PhD, PharmD, MBA, University of Washington, Seattle, WA
PS2-3

* CLINICAL EFFECTIVENESS AND COST-EFFECTIVENESS OF QUADRIVALENT HUMAN PAPILLOMAVIRUS VACCINATION IN HIV-NEGATIVE MEN WHO HAVE SEX WITH MEN TO PREVENT RECURRENT HIGH-GRADE ANAL INTRAEPITHELIAL NEOPLASIA
Ashish A. Deshmukh, MPH1, Elizabeth Chiao, MD, MPH2, Prajnan Das, MD, MS, MPH1 and Scott B. Cantor, Ph.D.3, (1)The University of Texas MD Anderson Cancer Center, Houston, TX, (2)Baylor College of Medicine, Houston, TX, (3)The University of Texas MD Anderson Cancer Center, Department of Health Services Research, Houston, TX
PS2-4

* TASK-SHARING OR PUBLIC FINANCE FOR THE EXPANSION OF SURGICAL ACCESS IN RURAL ETHIOPIA: AN EXTENDED COST-EFFECTIVENESS ANALYSIS
Mark G. Shrime, MD, MPH, Harvard University Interfaculty Initiative in Health Policy, Cambridge, MA, Stephane Verguet, MPP, PhD, University of Washington, Department of Global Health, Seattle, WA, Kjell Arne Johansson, MD PhD, Department of Global Public Health and Primary Care, Bergen University, Bergen, Norway, Dawit Desalegn, MD, Department of Obstetrics and Gynecology, Addis Ababa University School of Medicine, Addis Ababa, Ethiopia, Dean Jamison, PhD, Department of Global Health, University of Washington, Seattle, WA and Margaret Kruk, MD, MPH, Columbia Mailman School of Public Health, New York, NY
PS2-5

* WHAT ARE THE PUBLIC HEALTH IMPLICATIONS OF NEW BIOMARKERS FOR PROSTATE CANCER SCREENING?
Christine Barnett, B.Sc., M.Eng.1, Scott Tomlins, M.D., Ph.D.1, Todd Morgan, M.D.1, James Montie, MD2, John T. Wei, MD, MS1 and Brian Denton, B.Sc., M.Sc., Ph.D1, (1)University of Michigan, Ann Arbor, MI, (2)Department of Urology, Ann Arbor, MI
PS2-7

* COST-EFFECTIVENESS OF RAPID DIAGNOSTICS AND CARE SYSTEMS IMPROVEMENTS FOR TUBERCULOSIS IN INDIA
Sze-chuan Suen, MS1, Kimberly Babiarz, MA, PhD1, Eran Bendavid, MD, MS1 and Jeremy Goldhaber-Fiebert, PhD2, (1)Stanford University, Stanford, CA, (2)Stanford University, Stanford Health Policy, Centers for Health Policy and Primary Care and Outcomes Research, Department of Medicine, Stanford, CA
PS2-8

* THE LAMBDA COMPLEX: KNOWING YOUR PLACE IN THE THRESHOLD MATRIX
Mike Paulden, MA., MSc., University of Alberta, Edmonton, AB, Canada
PS2-9

* DETERMINANTS OF COST-EFFECTIVENESS OF ADALIMUMAB FOR RHEUMATOID ARTHRITIS
Christian Gissel, MSc, BA, Justus Liebig University, Giessen, Germany
PS2-10

* GET IT RIGHT OR OBTAIN IT CORRECTLY: THE ROLE OF READABILITY OF CONSENT FORMS IN DETERMINING DISCLOSURE RATES
Ester Moher, PhD and Khaled El Emam, PhD, University of Ottawa, Ottawa, ON, Canada
PS2-11

* SOME HEALTH STATES ARE CERTAINLY BETTER THAN OTHERS: USING HEALTH STATE RANK ORDER TO IMPROVE PROBABILISTIC SENSITIVITY ANALYSES
Hawre Jalal, MD, MSc, PhD and Jeremy D. Goldhaber-Fiebert, PhD, Stanford University, Stanford, CA
PS2-12

* THINKING FORWARD: THE TIME ORIENTATION OF PATIENTS MAKING TREATMENT DECISIONS
Joanna Hart, MD, Emily Pflug, BS, Vanessa Madden, BSc and Scott Halpern, MD PhD, University of Pennsylvania, Philadelphia, PA
PS2-13

* AN ITEM RESPONSE THEORY APPROACH FOR PREDICTING THE EQ-5D RESPONSES FROM THE SF-12
Marcelo Coca Perraillon, MA, Jong Bae Kim, Ph.D. and Robert Gibbons, Ph.D., University of Chicago, Chicago, IL
PS2-14

* COST-EFFECTIVENESS OF MULTIPLE SCLEROSIS DISEASE-MODIFYING THERAPY: ACCOUNTING FOR PATIENT RISK
Alexandra Leeper, JD1, Jeremy Goldhaber-Fiebert, PhD2, Douglas K. Owens, MD, MS1 and Alexandra Goodyear, MD, MS3, (1)Stanford University, Stanford, CA, (2)Stanford University, Stanford Health Policy, Centers for Health Policy and Primary Care and Outcomes Research, Department of Medicine, Stanford, CA, (3)Stanford School of Medicine, Stanford, CA
PS2-15

* PREDICTING THE EQ-5D PREFERENCE INDEX FROM THE SF-12 HEALTH SURVEY IN A NATIONAL US SAMPLE: A FINITE MIXTURE APPROACH
Marcelo Coca Perraillon, MA, Ya-Chen Tina Shih, Ph.D. and Ronald Thisted, Ph.D., University of Chicago, Chicago, IL
PS2-16

* TRADE-OFFS IN CERVICAL CANCER SCREENING – BALANCING DETECTED CANCER PRECURSORS AND RESOURCE USE
Kine Pedersen, BA1, Sveinung Wergeland Sørbye, MD, PhD2, Stefan Lönnberg, MD, PhD3, Emily Burger, MPhil1 and Ivar Sønbø Kristiansen, MD, PhD, MPH1, (1)University of Oslo, Oslo, Norway, (2)University Hospital of North Norway, Tromsø, Norway, (3)Cancer Registry of Norway, Oslo, Norway
PS2-17

* PERSPECTIVES IN UTILITY ESTIMATION OF VESICOURETERAL REFLUX - CHILD, PARENT, OR DYAD?
HsinHsiao Wang, MD, MPH, Jessica Lloyd, MD, John Wiener, MD and Jonathan Routh, MD, MPH, DUKE UNIVERSITY HEALTH SYSTEM, durham, NC
PS2-18

* THE ROLE OF SELF-EFFICACY IN PROSTATE CANCER TREATMENT DECISION MAKING
Maarten Cuypers, MSc.1, Romy R.E.D. Lamers, MD2, Marieke de Vries, PhD.1, Lonneke V. van de Poll-Franse, PhD.1 and Paul J.M. Kil, MD, PhD.2, (1)Tilburg University, Tilburg, Netherlands, (2)St. Elisabeth Hospital, Tilburg, Netherlands
PS2-19

* TAILORING, EXEMPLARS, AND AMOUNT OF INFORMATION IN AN ONLINE MAMMOGRAPHY DECISION AID: EFFECTS ON DECISION PROCESS OUTCOMES
Holli Seitz, MA, MPH1, Marilyn Schapira, MD, MPH2, Laura Gibson, PhD1, Christine Skubisz, MA, PhD3, Heather Forquer, MPH4, Susan Mello, MA, PhD5, Katrina Armstrong, MD6 and Joseph Cappella, PhD1, (1)Annenberg School for Communication, University of Pennsylvania, Philadelphia, PA, (2)University of Pennsylvania, Philadelphia, PA, (3)School of Communication, Emerson College, Boston, MA, (4)California Department of Public Health, Sacramento, CA, (5)College of Arts, Media, and Design, Northeastern University, Boston, MA, (6)Massachusetts General Hospital, Boston, MA
PS2-20

* COST-EFFECTIVENESS OF HAEMOPHILUS INFLUENZAE TYPE B VACCINE IN VIETNAM
Phuc Le, PhD1, Ulla Griffiths, PhD2, Anh Dang Duc, PhD3, Wenyaw Chan, PhD1, Luisa Franzini, PhD1 and J. Michael Swint, PhD1, (1)The University of Texas School of Public Health, Houston, TX, (2)London School of Hygiene and Tropical Medicine, London, United Kingdom, (3)National Institute of Hygiene and Epidemiology, Hanoi, Vietnam
PS2-21

* DEVELOPING AN INSTRUMENT TO ELICIT TREATMENT PREFERENCES FOR IDIOPATHIC PULMONARY FIBROSIS: ENGAGING PATIENTS THROUGH COGNITIVE INTERVIEWS
Victoria Federico Paly, BA1, Brittany A. Richardson, BS2, Sonye K. Danoff, MD, PhD2 and John F.P. Bridges, PhD1, (1)Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, (2)Johns Hopkins School of Medicine, Baltimore, MD
PS2-22

* MODELING DEPRESSION TREATMENT STRATEGIES FOR HUMAN IMMUNODEFICIENCY VIRUS INFECTED (HIV+) PATIENTS USING AGENT-BASED MODELING
Rongbing Xie, MPH1, Stephen T. Mennemeyer, Ph.D.2, Michael Mugavero, MD3 and Mirjam-Colette Kempf, Ph.D.3, (1)University of Alabama at Birmingham, Birmigham, AL, (2)University of Alabama at Birmingham School of Public Health, Birmingham, AL, (3)University of Alabama at Birmingham, Birmingham, AL
PS2-23

* UNDERESTIMATION OF VARIANCE OF MEAN UTILITIES DERIVED FROM MULTI-ATTRIBUTE UTILITY INSTRUMENTS: THE USE OF MULTIPLE IMPUTATION AS A POTENTIAL SOLUTION
Kelvin Chan, MD, MSc., Sunnybrook Odette Cancer Center, Toronto, ON, Canada, Feng Xie, PhD, McMaster University, Hamilton, ON, Canada and Eleanor Pullenayegum, PhD, The Hospital for Sick Children, Toronto, ON, Canada
PS2-24

* BAYESIAN NETWORK META-ANALYSIS OF DCIS RECURRENCE AFTER BREAST CONSERVING SURGERY: A TIME DEPENDANT HAZARD APPROACH
Joseph Levy, BS1, Marquita Decker, MD, MPH2 and David J. Vanness, Ph.D.1, (1)University of Wisconsin, Department of Population Health Sciences, Madison, WI, (2)University of Wisconsin, Department of Surgery, Madison, WI
PS2-25

* MAKING HEPATITIS C A RARE DISEASE IN THE UNITED STATES: MODEL-BASED PREDICTIONS
Mina Kabiri, MS1, Alison B. Jazwinski, MD2, Mark S. Roberts, MD1, Andrew J. Schaefer, PhD3 and Jagpreet Chhatwal, PhD4, (1)Department of Health Policy and Management, University of Pittsburgh, Pittsburgh, PA, (2)Division of Gastroenterology, Hepatology and Nutrition, University of Pittsburgh Medical Center, Pittsburgh, PA, (3)Department of Industrial Engineering, University of Pittsburgh, Pittsburgh, PA, (4)Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, TX
PS2-26

* SYSTEMATIC REVIEW AND META-ANALYSIS OF DIRECTLY OBSERVED THERAPY FOR TREATMENT OF HEPATITIS C
Cara McDermott, PharmD, MSc, Catherine Lockhart, PharmD and Emily Beth Devine, PhD, PharmD, MBA, University of Washington, Seattle, WA
PS2-27

* OPTIMIZING PARAMETERS FOR SCREENING MODELS: A REVIEW AND COMPARISON OF DIFFERENT GOODNESS OF FIT CRITERIA
Alex van der Steen, MSc1, Joost van Rosmalen, PhD2, Ewout W. Steyerberg, PhD1, Sonja Kroep, MSc1, Marjolein van Ballegooijen, MD, PhD1, Harry J. de Koning, MD, PhD1 and Iris Lansdorp-Vogelaar, PhD1, (1)Erasmus MC, University Medical Center, Department of Public Health, Rotterdam, Netherlands, (2)Erasmus MC, University Medical Center, Department of Biostatistics, Rotterdam, Netherlands
PS2-28

* PARTNERING OR PERSUADING: DECISION MAKING DURING CONSULTATIONS BETWEEN BREAST CANCER PATIENTS AND MEDICAL ONCOLOGISTS
Ellen G. Engelhardt, MSc.1, Arwen H. Pieterse, PhD1, Nanny van Duijn-Bakker, BSc.1, Anja van der Hout, MSc.1, Anine J. Griffioen, BSc.1, Judith R. Kroep, MD PhD1, Ellen MA Smets, PhD2, J. (Hanneke) CJM de Haes, PhD2 and Anne M. Stiggelbout, PhD1, (1)Leiden University Medical Center, Leiden, Netherlands, (2)Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands
PS2-29

* OPTIMIZING PARAMETERS FOR SCREENING MODELS: A COMPARISON OF DIFFERENT PARAMETER SEARCH ALGORITHMS
Alex van der Steen, MSc, Steffie K. Naber, MSc, Sonja Kroep, MSc, Tiago M. de Carvalho, MSc, Nicolien T. van Ravesteyn, PhD, Marjolein van Ballegooijen, MD, PhD and Iris Lansdorp-Vogelaar, PhD, Erasmus MC, University Medical Center, Department of Public Health, Rotterdam, Netherlands
PS2-30

* SCREENING HIGH-RISK MEN FOR ANAL CARCINOGENSIS: MODEL DEVELOPMENT AND POLICY ANALYSIS
Emily A. Burger, MPhil1, Joel Palefsky, MD2, Ivar Sønbø Kristiansen, MD, PhD, MPH1 and Jane J. Kim, PhD3, (1)University of Oslo, Oslo, Norway, (2)University of California, San Francisco, San Francisco, CA, (3)Harvard School of Public Health, Boston, MA
PS2-31

* THE APPLICATION OF CONTINUOUS-TIME SEMI-MARKOV MODELS IN HEALTH ECONOMIC DECISION MAKING: A CASE STUDY IN HEART FAILURE DISEASE MANAGEMENT
Qi Cao, Msc.1, Douwe Postmus, PhD1, Talitha Feenstra, PhD2, Hans L. Hillege, PhD, MD1 and Erik Buskens, MD, PhD1, (1)University Medical Center Groningen, Groningen, Netherlands, (2)RIVM, Bilthoven, Netherlands
PS2-32

* ETHNIC, GENDER, AND MARITAL STATUS DISPARITIES OF THE BURDEN OF CANCER-ATTRIBUTABLE INFECTIONS IN THE US: NHANES (1999-2012)
Kevin Moore, BA1, Erin Dunn, BA1, Qingyun Liu, MSc1, Stacey Tannenbaum, PhD2 and Tulay Koru-Sengul, MHS, PhD3, (1)University of Miami Miller School of Medicine, Miami, FL, (2)University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center, Miami, FL, (3)University of Miami Miller School of Medicine, Department of Public Health Sciences, Sylvester Comprehensive Cancer Center, Miami, FL
PS2-33

* INVESTIGATING THE FRAMING OF RISK ATTRIBUTES IN A DISCRETE CHOICE EXPERIMENT: AN APPLICATION OF EYE-TRACKING AND THINK ALOUD
Caroline Vass, BSc, MSc1, Dan Rigby, BSc, MSc, PhD2, Stephen Campbell, BA, MA, PhD3, Kelly Tate, BSc4, Andrew Stewart, BSc, PhD4 and Katherine Payne, BPharm, MSc, PhD1, (1)Manchester Centre for Health Economics, The University of Manchester, Manchester, United Kingdom, (2)Department of Economics, The University of Manchester, Manchester, United Kingdom, (3)Centre for Primary Care, The University of Manchester, Manchester, United Kingdom, (4)School of Psychological Sciences, The University of Manchester, Manchester, United Kingdom
PS2-34

* DO PATIENTS REALLY VALUE SHARED DECISION-MAKING? A PILOT CONTINGENT VALUATION STUDY
Logan Trenaman, BSc, Stirling Bryan, PhD and Nick Bansback, PhD, School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada
PS2-35

* PRIORITIZING CAREGIVERS' CONCERNS WITH INITIATING ADHD MEDICINE FOR THEIR CHILD: A BEST WORST SCALING PREFERENCE ELICITATION STUDY
Melissa Ross, MA1, John F.P. Bridges, PhD2, Xinyi Ng, BSc1, Emily J. Frosch, M.D.3, Gloria M. Reeves, M.D.4 and Susan dosReis, PhD1, (1)University of Maryland School of Pharmacy, Baltimore, MD, (2)Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, (3)Johns Hopkins School of Medicine, Baltimore, MD, (4)University of Maryland School of Medicine, Baltimore, MD
PS2-36

* EVALUATING THE CLINICAL UTILITY OF PREDICTION MODELS IN A HETEROGENEOUS MULTICENTER POPULATION USING DECISION-ANALYTIC MEASURES: THE RANDOM EFFECTS-WEIGHTED NET BENEFIT
Laure Wynants, MSc1, Dirk Timmerman, PhD, MD2, Sabine Van Huffel, PhD1 and Ben Van Calster, PhD2, (1)KU Leuven, Department of Electrical Engineering (ESAT), STADIUS Center for Dynamical Systems, Signal Processing and Data Analytics, Leuven, Belgium, (2)KU Leuven Department of Development and Regeneration, Leuven, Belgium
PS2-37

* CAREGIVERS' PREFERENCES FOR TREATMENT OPTIONS IN ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD): A BEST-WORST SCALING STUDY
Xinyi Ng, BSc (Pharm)1, John F.P. Bridges, PhD2, Melissa Ross, MA3, Mo Zhou, MHS2, Emily J. Frosch, M.D.4, Gloria M. Reeves, M.D.5 and Susan dosReis, PhD3, (1)University of Maryland Baltimore, Baltimore, MD, (2)Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, (3)University of Maryland School of Pharmacy, Baltimore, MD, (4)Johns Hopkins School of Medicine, Baltimore, MD, (5)University of Maryland School of Medicine, Baltimore, MD
PS2-38

* CALIBRATION OF PIECEWISE MARKOV MODELS USING A BAYESIAN CHANGE-POINT ANALYSIS THROUGH AN ITERATIVE CONVEX OPTIMIZATION ALGORITHM
Fernando Alarid-Escudero, MS1, Eva Enns, MS, PhD1, Richard Maclehose, MS, PhD2 and Karen M. Kuntz, ScD1, (1)University of Minnesota, Minneapolis, MN, (2)University of Minnesota, Epidemiology & Community Health, Minneapolis, MN
PS2-39

* USING SIMULATION MODELING TO COMPARE ALTERNATIVE LIFESTYLE APPROACHES AND PREVENT CARDIOVASCULAR DISEASE
Yan Li, M.S.1, Nan Kong, Ph.D.1, Mark Lawley, Ph.D.1 and José A. Pagán, Ph.D.2, (1)Purdue University, West Lafayette, IN, (2)The New York Academy of Medicine, New York, NY
PS2-40

* POTENTIAL BIAS ASSOCIATED WITH MODELING THE EFFECTIVENESS OF TREATMENT USING AN OVERALL HAZARD RATIO
Fernando Alarid-Escudero, MS and Karen M. Kuntz, ScD, University of Minnesota, Minneapolis, MN
PS2-42

* A FUZZY-TRACE THEORY ACCOUNT OF CONTRADICTORY RELATIONS BETWEEN RISK PERCEPTION AND RISK-TAKING IN VACCINATION DECISIONS
Priscila G. Brust-Renck, M.A., Valerie Reyna, PhD, Rebecca B. Weldon, PhD, Rebekah B. Foster, B.A. and Evan A. Wilhelms, M.S., Cornell University, Ithaca, NY
PS2-43

* “IT'S LIKE JAYWALKING ACROSS A BUSY STREET WITH YOUR EYES CLOSED, YOU'RE TAKING A CHANCE”: RISK COMMUNICATION AND VALUES CLARIFICATION IN A RADIATION ONCOLOGY CLINIC
Laurie Pilote, MD1, Emilie Brouillard, MD1, Luc Cote, PhD1, Selma Chipenda Dansokho, PhD1, Sindy Magnan, MD1, France Légaré, MD PhD1, Pierre Pluye, MD PhD2, Roland Grad, MD MSc2, Anik Giguère, PhD1 and Holly O. Witteman, PhD1, (1)Université Laval, Quebec City, QC, Canada, (2)McGill University, Montreal, QC, Canada
PS2-44

* SOCIETAL AND POLICY IMPLICATIONS FOR MEDICALLY NECESSARY SERVICES AND PREVENTIVE CARE IN THE U.S. TRANSGENDER POPULATION: A COST-EFFECTIVENESS ANALYSIS
William Padula, Ph.D., University of Chicago, Chicago, IL, Shiona Heru, J.D., Massachusetts Group Insurance Commission, Boston, MA and Jonathan D. Campbell, PhD, University of Colorado School of Pharmacy, Aurora, CO
PS2-45

* COST MINIMIZATION OF AFTER HOURS POSTOPERATIVE CARE FOR TRANSPLANT RECIPIENTS
William Padula, Ph.D., University of Chicago, Chicago, IL, Lisa McElroy, M.D., Northwestern University Transplant Outcomes Research Collaborative (NUTORC), Chicago, IL and Jane Holl, M.D., M.P.H., Center for Healthcare Studies, Northwestern University, Chicago, IL
PS2-46

* OPTIMIZING BREAST CANCER MAMMOGRAPHY SCREENING POLICIES CONSIDERING WOMEN'S ADHERENCE BEHAVIORS
Mahboubeh Madadi, Msc, Shengfan Zhang, PhD and Edward Pohl, PhD, University of Arkansas, Fayetteville, AR
PS2-6

* SOCIAL NORMATIVE BELIEFS ARE CENTRAL TO PATIENT CHOICE TO INTENSIFY THERAPY IN RHEUMATOID ARTHRITIS
Ryan Enck, BS, Michigan State University College of Human Medicine, Grand Rapids, MI and Richard W. Martin, MD, MA, Michigan State University, Grand Rapids, MI
PS2-41

* TRANSPARENCY ABOUT BENEFITS AND HARMS IS UNCOMMON IN RECOMMENDATIONS ON CANCER SCREENING & PREVENTION
Tanner Caverly, MD, MPH1, Elyse Reamer, BS2, Rodney Hayward, MD3, Michele Heisler, MD, MS3 and Angela Fagerlin, PhD4, (1)University of Michigan, Ann Arbor, MI, (2)University of Michigan Medical School, Ann Arbor, MI, (3)Ann Arbor VA HSR&D Center for Innovation, Ann Arbor, MI, (4)VA Ann Arbor Healthcare System & University of Michigan, Ann Arbor, MI

See more of: The 36th Annual Meeting of the Society for Medical Decision Making

<< Previous Session | Next Session >>